Loading...

Cogent Biosciences, Inc.

COGT•NASDAQ
Healthcare
Biotechnology
$36.81
$0.67(1.85%)
U.S. Market opens in 49h 27m

Cogent Biosciences, Inc. (COGT) Stock Overview

Explore Cogent Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap6B
P/E Ratio-7.56
EPS (TTM)$-2.16
ROE-1.00%
Fundamental Analysis

AI Price Forecasts

1 Month$34.67
3 Months$45.63
1 Year Target$26.99

COGT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Cogent Biosciences, Inc. (COGT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 52.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $26.99.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.56 and a market capitalization of 6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.85%
5-Day Change
-0.46%
1-Month Change
5.29%
3-Month Change
0.35%
6-Month Change
143.29%
Year-to-Date (YTD) Change
3.63%
1-Year Change
716.19%
3-Year Change
241.15%
5-Year Change
322.62%
All-Time (Max) Change
-17.17%

Contact Information

https://www.cogentbio.com
617 945 5576
200 Cambridge Park Drive, Waltham, MA, 02140

Company Facts

205 Employees
IPO DateMar 29, 2018
CountryUS
Actively Trading

Frequently Asked Questions